At Clinnex, pharmacovigilance goes beyond compliance, it is central to building patient trust and safeguarding product integrity.
At Clinnex, pharmacovigilance goes beyond compliance, it is central to building patient trust and safeguarding product integrity.
We deliver end-to-end PV services that help sponsors monitor safety, manage risks proactively, and meet global regulatory requirements across the product lifecycle.
With a combination of clinical expertise, robust processes, and technology-enabled systems, we ensure that every safety signal is identified, evaluated, and addressed with precision and timeliness.
At Clinnex, pharmacovigilance goes beyond compliance, it is central to building patient trust and safeguarding product integrity.
We deliver end-to-end PV services that help sponsors monitor safety, manage risks proactively, and meet global regulatory requirements across the product lifecycle.
With a combination of clinical expertise, robust processes, and technology-enabled systems, we ensure that every safety signal is identified, evaluated, and addressed with precision and timeliness.
We ensure timely detection, evaluation, and reporting of safety information across the product lifecycle.
End-to-end management of individual case safety reports—from intake and MedDRA coding to narrative writing, medical review, and expedited reporting—ensuring accuracy and compliance.
Preparation of PSURs, DSURs, RMPs, and other regulatory documents aligned with global standards, supported by meaningful safety insights for informed decision-making.
Proactive identification, validation, and assessment of safety signals using global databases and literature—enabling timely risk mitigation and regulatory action.
Comprehensive clinical evaluation of safety data, including causality and severity assessment, supported by experienced medical professionals.
Continuous monitoring of global medical literature to identify safety signals, ICSRs, and emerging trends—ensuring no critical information is missed.
Ongoing clinical oversight of trials, including SAE review, safety trend analysis, and support for safety-related decision-making.
Development of tailored, risk-based safety strategies aligned with study design, therapeutic area, and regulatory requirements.
Ensuring continuous compliance through PV audits, CAPA management, SOP development, and preparation for global regulatory inspections.
Secure, compliant, and scalable management of safety databases ensuring data integrity, traceability, and readiness for reporting and audits.
We ensure timely detection, evaluation, and reporting of safety information across the product lifecycle.
End-to-end management of individual case safety reports—from intake and MedDRA coding to narrative writing, medical review, and expedited reporting—ensuring accuracy and compliance.
Preparation of PSURs, DSURs, RMPs, and other regulatory documents aligned with global standards, supported by meaningful safety insights for informed decision-making.
Proactive identification, validation, and assessment of safety signals using global databases and literature—enabling timely risk mitigation and regulatory action.
Comprehensive clinical evaluation of safety data, including causality and severity assessment, supported by experienced medical professionals.
Continuous monitoring of global medical literature to identify safety signals, ICSRs, and emerging trends—ensuring no critical information is missed.
Ongoing clinical oversight of trials, including SAE review, safety trend analysis, and support for safety-related decision-making.
Development of tailored, risk-based safety strategies aligned with study design, therapeutic area, and regulatory requirements.
Ensuring continuous compliance through PV audits, CAPA management, SOP development, and preparation for global regulatory inspections.
Secure, compliant, and scalable management of safety databases ensuring data integrity, traceability, and readiness for reporting and audits.
We adopt a risk-based, lifecycle-driven approach to pharmacovigilance - integrating safety monitoring across clinical development and post-marketing phases. By combining real-time data evaluation, cross-functional collaboration, and regulatory alignment, we ensure proactive risk management and consistent compliance. Our processes are designed to be scalable, transparent, and audit-ready - helping sponsors stay ahead of evolving regulatory expectations.
Comprehensive safety oversight that ensures compliance, mitigates risk, and strengthens patient trust.
Comprehensive safety oversight that ensures compliance, mitigates risk, and strengthens patient trust.
With Clinnex as your pharmacovigilance partner, you gain reliable safety management, faster regulatory readiness, and the confidence to focus on innovation—while we safeguard your product’s safety and reputation.
Comprehensive safety oversight that ensures compliance, mitigates risk, and strengthens patient trust.
With Clinnex as your pharmacovigilance partner, you gain reliable safety management, faster regulatory readiness, and the confidence to focus on innovation—while we safeguard your product’s safety and reputation.
With a strong foundation in biometrics and clinical operations, we deliver precise, compliant, and scalable solutions. We work as an extension of our clients’ team ensuring efficiency, transparency, and measurable impact at every stage.
Global expertise across pharmacovigilance standards and regulations.
Experienced team of PV specialists, medical reviewers, and data experts.
Technology-enabled processes for accuracy, speed, and transparency.
End-to-end support across the entire pharmacovigilance lifecycle.
